Lumos Pharma, Inc. (LUMO)
NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.0200 |
| Open | 3.0500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.7300 - 3.0500 |
| 52-week range | 2.4100 - 4.5500 |
| Volume | |
| Avg. volume | 26,722 |
| Market cap | 23.538M |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Lumos Pharma ( NASDAQ:LUMO ) Full Year 2023 Results Key Financial Results Net loss: US$34.0m (loss widened by 9.6% from...
- Insider Monkey
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript
Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript March 7, 2024 Lumos Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Lumos Pharma’s 2023 Fourth Quarter and Year End Conference Call. Currently all […]
- Simply Wall St.
Is Lumos Pharma (NASDAQ:LUMO) In A Good Position To Invest In Growth?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2024 Yahoo. All rights reserved.